手术前抗生素(头孢唑啉)对 I-II 期黑色素瘤患者微生物组的影响
评估围手术期抗生素预防对皮肤恶性肿瘤患者微生物组的影响
This phase I trial investigates the impact of cefazolin before surgery on the microbiome in patients with stage I-II melanoma. Antibiotics, such as cefazolin, given at the time of surgery may cause a significant change in the microbes (like bacteria and viruses) found in the stomach and intestines. This trial may help researchers learn if any changes in microbes affect the body's ability to respond to surgery and cancer.
研究概览
地位
条件
- 临床 I 期皮肤黑色素瘤 AJCC v8
- 临床 IA 期皮肤黑色素瘤 AJCC v8
- 临床 IB 期皮肤黑色素瘤 AJCC v8
- 临床 II 期皮肤黑色素瘤 AJCC v8
- 临床 IIA 期皮肤黑色素瘤 AJCC v8
- 临床 IIB 期皮肤黑色素瘤 AJCC v8
- 临床 IIC 期皮肤黑色素瘤 AJCC v8
- 病理 I 期皮肤黑色素瘤 AJCC v8
- 病理 IA 期皮肤黑色素瘤 AJCC v8
- 病理学阶段 IB 皮肤黑色素瘤 AJCC v8
- 病理学 II 期皮肤黑色素瘤 AJCC v8
- 病理 IIA 期皮肤黑色素瘤 AJCC v8
- 病理 IIB 期皮肤黑色素瘤 AJCC v8
- 病理 IIC 期皮肤黑色素瘤 AJCC v8
干预/治疗
详细说明
PRIMARY OBJECTIVE:
I. To investigate whether the use of pre-operative prophylactic antibiotics administered during surgical resection substantially alters the patient's gut microbiome.
SECONDARY OBJECTIVES:
I. To characterize the dynamics of the immune response to surgical intervention in the absence and presence of pre-operative prophylactic antibiotics, focusing on the immune profile of the peripheral blood leukocytes as well as the balance of circulating pro- and anti-inflammatory cytokines and metabolomic profiles.
II. To assess surgical site infection (SSI) in the absence and presence of pre-operative prophylactic antibiotics at time of surgical resection.
OUTLINE: Patients are randomized to 1 of 2 arms.
ARM A: Patients receive cefazolin intravenously (IV) and then undergo standard of care surgical resection within 1 hour.
ARM B: Patients undergo standard of care surgical resection.
After completion of study treatment, patients are followed up at 3 days, 2 weeks, and 3 months.
研究类型
注册 (估计的)
阶段
- 阶段1
联系人和位置
学习地点
-
-
Texas
-
Houston、Texas、美国、77030
- M D Anderson Cancer Center
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Adult subjects with early stage melanoma (stage I-II)
- Patients must be undergoing wide local excision +/- sentinel lymph node biopsy
- Patients must be capable of giving written informed consent, which includes compliance with the requirements and restrictions listed in the consent form
Exclusion Criteria:
- Use of antibiotics within the three months prior to surgery
- Allergy, sensitivity or anaphylaxis to beta-lactam or cephalosporin antibiotics
- Presence of an infection at the time of surgery
- Increased risk of infection due to a co-existing medical condition as determined by the surgical team or principal investigator (PI)
- Subjects with a condition requiring systemic treatment with either corticosteroids (> 10 mg daily prednisone equivalents) or other immunosuppressive medications within 14 days of study drug administration
- American Society of Anesthesiologists (ASA) grade > IV
- Refusal to participate in the study
- Patients who are pregnant will not be included in this study
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
有源比较器:Arm A (cefazolin, surgical resection)
Patients receive cefazolin IV and then undergo standard of care surgical resection within 1 hour. |
Given IV Undergo standard of care surgical resection
其他名称:
|
|
实验性的:Arm B (surgical resection)
Patients undergo standard of care surgical resection. |
Undergo standard of care surgical resection
其他名称:
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Change in microbiome alpha diversity
大体时间:Baseline up to 2 weeks post-surgery
|
The diversity, structure, and composition of the fecal microbiome will be determined by 16S(v4) rRNA gene sequencing. 16S profiles will be used to compute alpha diversity, beta diversity, and the relative abundance of fecal bacteria. The composition of fecal bacteria in adult humans is mainly dominated by members of the Firmicutes and Proteobacteria phyla while members of Proteobacteria, Actinobacteria, Fusobacteria, and Verrucomicrobia are observed in lower abundance. To calculate richness (alpha-diversity), we will count each operational taxonomic unit (OTU) or amplicon sequence variant (ASV) identified. Richness count is expected to range between 10-500 per sample. |
Baseline up to 2 weeks post-surgery
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
微生物相对丰度的变化
大体时间:基线,术后 2 周和术后 3 个月
|
基线,术后 2 周和术后 3 个月
|
|
|
伤口(手术部位)感染率
大体时间:手术后长达 3 个月
|
手术后长达 3 个月
|
|
|
Change in microbiome diversity
大体时间:Baseline up to 3 months post-surgery
|
The diversity, structure, and composition of the fecal microbiome will be determined by 16S(v4) rRNA gene sequencing. 16S profiles will be used to compute alpha diversity, beta diversity, and the relative abundance of fecal bacteria. The composition of fecal bacteria in adult humans is mainly dominated by members of the Firmicutes and Proteobacteria phyla while members of Proteobacteria, Actinobacteria, Fusobacteria, and Verrucomicrobia are observed in lower abundance. To calculate richness (alpha-diversity), we will count each operational taxonomic unit (OTU) or amplicon sequence variant (ASV) identified. Richness count is expected to range between 10-500 per sample. |
Baseline up to 3 months post-surgery
|
|
Profiling of systemic immune function by analysis of composition of circulating immune cell populations and cytokines
大体时间:Up to 3 months post-surgery
|
By analysis of composition of circulating immune cell populations and cytokines. |
Up to 3 months post-surgery
|
合作者和调查者
调查人员
- 首席研究员:Emily Z Keung、M.D. Anderson Cancer Center
出版物和有用的链接
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.